Table 3.

Patient Outcomes

Outcome	PCC3 (n = 57)	PCC4 (n = 23)	p
Patients achieving INR ≤ 1.5, n (%)	18 (31.6%)	20 (87.0%)	< 0.001
Intracranial bleeding	10 (32.3%)	16 (84.2%)
Gastrointestinal bleeding	4 (40.0%)	2 (100%)
Other bleeding	4 (75%)	2 (100%)
Death during hospitalization, n (%)	14 (24.7%)	8 (34.8%)	0.52
Intracranial bleeding	10 (32.3%)	7 (36.8%)
Gastrointestinal bleeding	1 (10.0%)	0 (0%)
Other bleeding	3 (75%)	1 (50%)
Length of stay
Overall	6.0 (4.0–11.0)	6.0 (2.5–10.0)	0.47
Survivors	6.5 (4.0–10.0)	6.0 (3.0–9.5)	0.52
Thromboembolic events, n (%)	5 (8.8%)	2 (8.7%)	1.0

INR international normalized ratio, PCC prothrombin complex concentrate, PCC3 3-factor PCC, PCC4 4-factor PCC